dobutamine has been researched along with Shock, Cardiogenic in 112 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 29 (25.89) | 18.7374 |
| 1990's | 15 (13.39) | 18.2507 |
| 2000's | 20 (17.86) | 29.6817 |
| 2010's | 25 (22.32) | 24.3611 |
| 2020's | 23 (20.54) | 2.80 |
| Authors | Studies |
|---|---|
| Abdel-Razek, O; Bernick, J; Di Santo, P; Fu, A; Gillmore, T; Hibbert, B; Jung, RG; Labinaz, M; Lau, L; Mao, B; Marbach, JA; Mathew, R; Motazedian, P; Parlow, S; Russo, JJ; Simard, T; Theriault-Lauzier, P | 1 |
| Potter, BJ | 1 |
| Berra, L; Chang, MG; Gibson, LE | 1 |
| Di Santo, P; Hibbert, B; Mathew, R | 1 |
| Abdel-Razek, O; Di Santo, P; Fernando, SM; Froeschl, M; Hibbert, B; Jung, RG; Kapur, NK; Labinaz, M; Marbach, JA; Mathew, R; Parlow, S; Simard, T; Thayer, KL | 1 |
| Bandyopadhyay, D; Biswas, S; Briasoulis, A; Fonarow, GC; Goel, A; Gupta, R; Lanier, GM; Malik, AH; Naidu, SS | 1 |
| Blumer, V; Kanwar, M; Marbach, J; Veasey, T | 1 |
| Barhoum, P; Bréchot, N; Chommeloux, J; Combes, A; de Chambrun, MP; Franchineau, G; Hékimian, G; Lebreton, G; Lefèvre, L; Luyt, CE; Montero, S; Schmidt, M | 1 |
| Abdel-Razek, O; Di Santo, P; Froeschl, M; Fu, A; Hibbert, B; Hutson, J; Jung, RG; Malhotra, N; Mathew, R; Motazedian, P; Parlow, S; Prosperi-Porta, G; Ramirez, FD; Simard, T | 1 |
| Hu, K; Mathew, R | 1 |
| Ahrens, I; Gierlotka, M; Grand, J; Hassager, C; Price, S; Rossello, X; Sionis, A; Tavazzi, G | 1 |
| Abdel-Razek, O; Cheung, M; Di Santo, P; Fernando, SM; Hibbert, B; Hutson, JH; Jung, RG; Malhotra, N; Marbach, JA; Mathew, R; Motazedian, P; Nair, GM; Nery, PB; Parlow, S; Ramirez, FD; Russo, JJ; Simard, T; Thibert, MJ; Weng, W | 1 |
| Ishii, T; Izawa, K; Kinoshita, M; Masuda, M; Onoda, T; Sato, N; Tanaka, H; Urano, A | 1 |
| AlDharrab, AS; Algazzar, AS; Alnajjar, TA; Andijani, AMA; Fida, HL; Qutub, MA; Taiyeb, AM | 1 |
| Billia, F; Brahmbhatt, DH; Fung, NL; Luis Scolari, F; Luk, A; Mihajlovic, V; Otsuki, M; Overgaard, CB; Rodenas-Alesina, E; Wang, VN | 1 |
| Aissaoui, N; Bataille, V; Biendel, C; Bonello, L; Bonnefoy, E; Bourenne, J; Cariou, A; Champion, S; Combaret, N; Curtiaud, A; Delmas, C; Gantzer, J; Gerbaud, E; Harbaoui, B; Khachab, H; Kurtz, JE; Lamblin, N; Lattuca, B; Leurent, G; Levy, B; Lim, P; Marchandot, B; Merdji, H; Puymirat, E; Quentin, C; Roubille, F; Schneider, F; Schurtz, G; Seronde, MF; Vanzetto, G | 1 |
| Chen, X; Lei, J; Liao, X; Qian, L; Zhang, S | 1 |
| Efremov, L; Frantz, S; Mikolajczyk, R; Schumann, J; Sedding, D; Tongers, J; Uhlig, K | 1 |
| Alvarez, J; Bettex, D; Bouchez, S; Fruhwald, S; Girardis, M; Grossini, E; Guarracino, F; Heringlake, M; Herpain, A; Pollesello, P; Toller, W; Tritapepe, L | 1 |
| Arias Ortiz, J; De Backer, D; Levy, B | 1 |
| Abdel-Razek, O; Almufleh, A; Bernick, J; Chan, V; Di Santo, P; Fernando, SM; Froeschl, M; Harnett, DT; Hibbert, B; Hutson, J; Jung, RG; Kyeremanteng, K; Labinaz, M; Le May, MR; Marbach, JA; Mathew, R; Merdad, A; Ramirez, FD; Russo, JJ; Simard, T; Wells, GA; Weng, W | 1 |
| Abdel-Razek, O; Bernick, J; Boczar, KE; D'Egidio, G; Di Santo, P; Dick, A; Glover, C; Hawken, S; Hibbert, B; Jung, RG; Mao, B; Marbach, JA; Mathew, R; McGuinty, C; Motazedian, P; Parlow, S; Ramirez, FD; Russo, JJ; Simard, T; Skanes, S; So, DY; Wells, GA | 1 |
| Abdel-Razek, O; Di Santo, P; Dick, A; Fernando, SM; Froeschl, M; Gillmore, T; Glover, C; Hibbert, B; Jung, RG; Labinaz, M; Mao, B; Marbach, JA; Mathew, R; Parlow, S; Ramirez, FD; Russo, JJ; Simard, T | 1 |
| Frantz, S; Henrich, EC; Prondzinsky, R; Schumann, J; Strobl, H; Thiele, H; Unverzagt, S; Weiche, S; Werdan, K | 1 |
| Acosta-Delgado, D; Corcia-Palomo, Y; Escalona-Rodriguez, S; Martin-Bermudez, R; Martin-Villen, L; Roldan-Reina, A | 1 |
| Aberle, C; Altshuler, D; Lewis, TC; Papadopoulos, J; Piper, GL | 1 |
| Anker, SD; Balligand, JL; Bauersachs, J; Brutsaert, D; Carrier, L; Chlopicki, S; Cleland, JG; de Boer, RA; de Keulenaer, G; Dietl, A; Eschenhagen, T; Fischmeister, R; Hamdani, N; Harjola, VP; Heinzel, FR; Heymans, S; Hilfiker-Kleiner, D; Holzmeister, J; Limongelli, G; Linke, WA; Lund, LH; Lyon, AR; Maack, C; Manstein, DJ; Masip, J; Mebazaa, A; Metra, M; Metzger, J; Mueller, C; Papp, Z; Pieske, B; Ponikowski, P; Ristić, A; Ruschitzka, F; Seferović, PM; Skouri, H; Tocchetti, CG; Yilmaz, MB; Zimmermann, WH | 1 |
| Choi, CH; Jeon, YB; Lee, JI; Moon, JK; Park, CH; Park, KY | 1 |
| Bigam, D; Cheung, PY; Dicken, B; Gill, RS; LaBossiere, J; Pelletier, JS; Sergi, C; Tahbaz, N | 1 |
| Bugan, B; Celik, M; Yalcinkaya, E | 1 |
| Buerke, M; Haerting, J; Hirsch, K; Prondzinsky, R; Thiele, H; Unverzagt, S; Wachsmuth, L; Werdan, K | 1 |
| Cepeda, JM; Conthe, P | 1 |
| Constantinescu, AA; den Uil, CA; Jewbali, LS; Lagrand, WK; Nieman, K; Simoons, ML; Spronk, PE; Struijs, A; van der Ent, M | 1 |
| Aronow, WS; Fallon, JT; Frishman, WH; Gass, A; Gupta, T; Khera, S; Kolte, D; Pinnamaneni, S; Singh, T | 1 |
| Du, ZH; Hu, B; Li, JG; Lu, ZH; Ma, PL; Pei, XB; Yun, L; Zhou, Q | 1 |
| Chacko, B; D'sa, SR; Peter, JV; Pichamuthu, K; Sathyendra, S | 1 |
| Akodad, M; Lim, P; Roubille, F | 1 |
| Castro-Garay, JC; Cruz-González, I; Martín-Moreiras, J; Sánchez, PL; Uribarri, A | 1 |
| Bulsara, M; Chamberlain, J; Harding, R; Ho, KM | 1 |
| Arlt, A; El Mokhtari, NE; Lins, M; Meissner, A | 2 |
| Good, CW; Harrison, TA; Hubbard, CR; Qureshi, A | 1 |
| Adhyapak, S; Iyengar, S; Jaydev, S; Patil, C; Shetty, G; Siddaiah, L; Varghese, K | 1 |
| Yalta, K; Yilmaz, MB; Yontar, OC | 1 |
| Gjessing, PF; Hermansen, SE; How, OJ; Kildal, AB; Myrmel, T; Røsner, A; Stenberg, TA | 1 |
| Gerard, A; Levy, B; Perez, P; Perny, J; Thivilier, C | 1 |
| Baud, FJ; Deye, N; Mégarbane, B; Voicu, S | 1 |
| Delle Karth, G; Krenn, L | 1 |
| Aguasca, GM; del Blanco, BG; García-Dorado García, D; Mas, PT; Mercè, AS; Rius, JB | 1 |
| Bonnefoy, E; Cottin, V; Courand, PY; Croisille, P; Khouatra, C; Kirkorian, G | 1 |
| Attof, R; Malfroy, S; Perdrix, JP; Piriou, V; Tassin, C | 1 |
| Besancon, A; de Haro, L; Glaizal, M; Hayek-Lanthois, M; Klouche, K; Schmitt, C; Tichadou, L | 1 |
| Bur, A; Glogar, D; Herkner, H; Hirschl, MM; Huber, K; Koreny, M; Laggner, AN; Schreiber, W | 1 |
| Dupuis, M; Fléron, MH; Godet, G; Le Feuvre, C; Mottet, P | 1 |
| Follath, F | 1 |
| Close, L; Lemaitre, F; Plein, D; Silance, PG; Vandenbossche, JL | 1 |
| Hausmann, H; Hennig, F; Hetzer, R; Lehmkuhl, HB; Potapov, EV; Sodian, R; Volk, HD; Wagner, FD | 1 |
| Noori, S; Seri, I | 1 |
| Bakouboula, B; Chauvin, M; Douchet, MP; Morel, O | 1 |
| Abreu-González, P; Domínguez-Rodríguez, A; Ferrer-Hita, JJ; García-González, MJ; Muñoz, MB | 1 |
| Hennersdorf, M; Müller, K; Peters, A; Strauer, BE; Zeus, T | 1 |
| Buisine, A; Chevret, L; Decobert, M; Devictor, D; Durand, P; Haas, V; Tiras, S; Tissières, P | 1 |
| Mardelle, V; Peytel, E; Ramiara, P; Xeridat, F | 1 |
| Abreu-González, P; Domínguez-Rodríguez, A; García-González, MJ; Samimi-Fard, S | 2 |
| Antończyk, A; Kochman, K; Magdalan, J; Porebska, B | 1 |
| Buerke, M; Buerke, U; Carter, JM; Christoph, A; Lemm, H; Prondzinsky, R; Reith, S; Russ, MA; Schlitt, A; Söffker, G; Swyter, M; Wegener, N; Werdan, K; Winkler, M | 1 |
| Bretsztajn, A; Cupa, M; Gabry, A; Hoang The Dan, P; Pourriat, JL | 1 |
| Kedra, WA; Kutarski, A; Markiewicz, M; Rymar, B; Trojnar, R | 1 |
| Rude, RE | 1 |
| Bardet, J; Bourdarias, JP; Dubourg, O; Ferrier, A; Gueret, P | 1 |
| Bussmann, WD; Wehrheim, HG | 1 |
| Dabasaki, T; Funato, H; Ohnishi, H; Sato, M; Uemura, A; Yamaguchi, K | 1 |
| Brandt, D; Klein, W; Pristautz, H | 1 |
| Machii, K | 1 |
| Cyran, J | 1 |
| Chamberlain, DA; Crick, JP; Fowler, MB; Timmis, AD; Vincent, R | 1 |
| Auzepy, P; Bottineau, G; Richard, C; Ricome, JL; Rimailho, A | 1 |
| Gunnar, RM; Loeb, HS | 1 |
| Hugenholtz, PG; Muskens, G; Simoons, ML | 1 |
| Alt, E; Franke, N; Holtz, J; Kemkes, B; Kreuzer, E; Reichart, B; Schmucker, P; Türk, R | 1 |
| Houston, MC | 1 |
| Francis, GS; Hodges, M; Sharma, B | 1 |
| Dirschinger, J; Rudolph, W | 1 |
| Coma Canella, I; López-Sendón, J | 1 |
| Matsumura, S; Morishige, E; Ueda, M; Uno, O | 1 |
| Iqbal, MZ; Liebson, PR | 1 |
| Alonso Francia, C; Calvo Cebollero, I; Diarte de Miguel, JA; Gomollón García, JP; Placer Peralta, LJ | 1 |
| Doody, DP; Reynolds, EM; Ryan, DP; Sheridan, RL | 1 |
| Bernard, F; Bertin-Maghit, M; Bouchard, C; Gueugniaud, PY; Petit, P; Vilasco, B | 1 |
| Boulain, T; Lanotte, R; Legras, A; Perrotin, D | 1 |
| Kontoyannis, DA; Moulopoulos, SD; Nanas, JN; Nanas, SN; Stamateolopoulos, SF | 1 |
| Alpert, JS; Becker, RC | 1 |
| Doyon, S; Roberts, JR | 1 |
| Alba, D; Garcia, B; Sosa, P; Torres, E | 1 |
| Meissner, A; Schmelzle, T; Simon, R | 1 |
| Geshi, E; Itoh, S; Katagiri, T; Konno, N; Mukae, S; Tomita, M; Umetsu, K; Yanagishita, T | 1 |
| Chen, YS; Chou, NK; Chou, TF; Chu, SH; Hsu, RB; Ko, WJ; Lin, FY; Wang, SS | 1 |
| Dixon, DW; Gunnar, RM; Loeb, HS | 1 |
| Benzer, H | 1 |
| Bauer, P; Bollaert, PE; Lambert, H; Larcan, A; Maire, B; Weber, M | 1 |
| Benvenuti, C; Cachera, JP; Castaigne, A; Deleuze, P; Dubois-Randé, JL; Duval-Moulin, AM; Lellouche, D; Loisance, D; Merlet, P; Saal, JP | 1 |
| Fujii, T; Fujii, Z; Furutani, Y; Kusukawa, R; Matsuda, Y; Matsuzaki, M; Ogawa, H | 1 |
| Creamer, JE; Edwards, JD; Nightingale, P | 1 |
| Littler, WA; Tan, LB | 1 |
| Crockett, M; Tappero, E | 1 |
| Ritz, R | 1 |
| Kleinschmidt, R; Spannbrucker, N; Vogel, F | 1 |
| Erbel, R; Esser, MJ; Henrichs, KJ; Meyer, J; Pop, T | 1 |
| Bundage, B; Evans, T; Kram, HB; Shoemaker, WC | 1 |
| Mueller, HS | 1 |
| Beck, OA | 1 |
22 review(s) available for dobutamine and Shock, Cardiogenic
| Article | Year |
|---|---|
Meta-analysis Comparing the Efficacy of Dobutamine Versus Milrinone in Acute Decompensated Heart Failure and Cardiogenic Shock.
Topics: Cardiotonic Agents; Dobutamine; Heart Failure; Humans; Milrinone; Randomized Controlled Trials as Topic; Retrospective Studies; Shock, Cardiogenic | 2023 |
Role of medical management of cardiogenic shock in the era of mechanical circulatory support.
Topics: Cardiotonic Agents; Dobutamine; Humans; Shock, Cardiogenic; Treatment Outcome; Vasoconstrictor Agents | 2022 |
Inotrope and vasopressor use in cardiogenic shock: what, when and why?
Topics: Cardiotonic Agents; Dobutamine; Humans; Shock, Cardiogenic; Simendan; Vasoconstrictor Agents | 2022 |
Network Meta-Analysis of the Safety of Drug Therapy for Cardiogenic Shock.
Topics: Aged; Disease Progression; Dobutamine; Dopamine; Epinephrine; Female; Hemodynamics; Humans; Male; Middle Aged; Milrinone; Natriuretic Peptide, Brain; Network Meta-Analysis; Norepinephrine; Patient Safety; Recombinant Proteins; Shock, Cardiogenic; Simendan; Treatment Outcome | 2020 |
Inotropic agents and vasodilator strategies for the treatment of cardiogenic shock or low cardiac output syndrome.
Topics: Aged; Cardiac Output, Low; Cardiotonic Agents; Cause of Death; Dobutamine; Enoximone; Epinephrine; Humans; Hydrazones; Middle Aged; Myocardial Infarction; Nitric Oxide; Placebos; Pyridazines; Randomized Controlled Trials as Topic; Shock, Cardiogenic; Simendan; Vasodilator Agents | 2020 |
An update on levosimendan in acute cardiac care: applications and recommendations for optimal efficacy and safety.
Topics: Adrenergic beta-Antagonists; Cardiac Surgical Procedures; Cardiotonic Agents; Critical Care; Dobutamine; Heart Failure; Hemodynamics; Humans; Shock, Cardiogenic; Simendan | 2021 |
The medical treatment of cardiogenic shock: cardiovascular drugs.
Topics: Cardiotonic Agents; Cardiovascular Agents; Dobutamine; Humans; Shock; Shock, Cardiogenic; Vasoconstrictor Agents | 2021 |
Inotropic agents and vasodilator strategies for the treatment of cardiogenic shock or low cardiac output syndrome.
Topics: Aged; Cardiac Output, Low; Cardiotonic Agents; Cause of Death; Dobutamine; Enoximone; Humans; Hydrazones; Middle Aged; Myocardial Infarction; Nitric Oxide; Pyridazines; Randomized Controlled Trials as Topic; Shock, Cardiogenic; Simendan; Vasodilator Agents | 2018 |
Inotropic agents and vasodilator strategies for acute myocardial infarction complicated by cardiogenic shock or low cardiac output syndrome.
Topics: Cardiac Output, Low; Cardiotonic Agents; Dobutamine; Enoximone; Humans; Hydrazones; Myocardial Infarction; Nitric Oxide; Pyridazines; Randomized Controlled Trials as Topic; Shock, Cardiogenic; Simendan; Vasodilator Agents | 2014 |
[Possibilities of clinical echocardiography in patients with heart failure: some examples from clinical practice].
Topics: Acute Coronary Syndrome; Acute Disease; Aged; Arrhythmias, Cardiac; Counterpulsation; Diagnostic Errors; Dobutamine; Dyspnea; Echocardiography; Gastroenteritis; Heart Failure; Humans; Male; Middle Aged; Myocarditis; Norepinephrine; Point-of-Care Systems; Pulmonary Embolism; Radiography; Respiration, Artificial; Shock, Cardiogenic; Stroke Volume; Systole | 2014 |
[Acute myocarditis: from chest pain to cardiogenic shock].
Topics: Acute Disease; Adult; Aged; Aspirin; Biopsy; Cardiotonic Agents; Chest Pain; Clinical Enzyme Tests; Diagnosis, Differential; Dobutamine; Dopamine; Echocardiography; Electrocardiography; Endocardium; Female; Humans; Male; Myocarditis; Myocardium; Platelet Aggregation Inhibitors; Prognosis; Shock, Cardiogenic; Stroke Volume; Time Factors; Treatment Outcome; Ventricular Function, Left | 2005 |
Diagnosis and treatment of neonatal hypotension outside the transitional period.
Topics: Adrenal Insufficiency; Dobutamine; Dopamine; Ductus Arteriosus, Patent; Humans; Hypotension; Infant, Newborn; Infant, Premature; Infant, Premature, Diseases; Infant, Very Low Birth Weight; Milrinone; Neonatology; Shock, Cardiogenic; Systemic Inflammatory Response Syndrome | 2005 |
Pharmacologic support in cardiogenic shock.
Topics: Animals; Cardiotonic Agents; Diagnosis, Differential; Digitalis Glycosides; Diuretics; Dobutamine; Dopamine; Humans; Isoproterenol; Monitoring, Physiologic; Myocardial Infarction; Norepinephrine; Shock, Cardiogenic; Syndrome; Vasodilator Agents | 1983 |
Inotropic agents in the treatment of cardiogenic shock.
Topics: Cardiac Output, Low; Cardiac Tamponade; Cardiotonic Agents; Catecholamines; Digitalis; Dobutamine; Dopamine; Glucagon; Humans; Isoproterenol; Metaraminol; Methoxamine; Myocardial Infarction; Norepinephrine; Phenylephrine; Plants, Medicinal; Plants, Toxic; Pulmonary Embolism; Shock, Cardiogenic | 1983 |
Diagnosis and treatment of shock.
Topics: Dobutamine; Dopamine; Humans; Shock; Shock, Cardiogenic; Shock, Septic | 1980 |
[Therapeutic options in cardiogenic shock].
Topics: Amrinone; Angioplasty, Balloon, Coronary; Assisted Circulation; Cardiotonic Agents; Coronary Artery Bypass; Dobutamine; Dopamine; Humans; Milrinone; Myocardial Infarction; Nitroglycerin; Phosphodiesterase Inhibitors; Pyridones; Shock, Cardiogenic; Thrombolytic Therapy; Vasodilator Agents | 1995 |
Mechanisms and management of cardiogenic shock.
Topics: Critical Care; Dobutamine; Dopamine; Heart Transplantation; Hemodynamics; Humans; Intra-Aortic Balloon Pumping; Monitoring, Physiologic; Myocardial Reperfusion; Shock, Cardiogenic | 1993 |
Use of catecholamines in acute myocardial infarction.
Topics: Animals; Blood Volume; Catecholamines; Dobutamine; Dogs; Dopamine; Epinephrine; Hemodynamics; Humans; Isoproterenol; Myocardial Infarction; Norepinephrine; Shock, Cardiogenic | 1979 |
Dopamine and dobutamine: neonatal indications and implications.
Topics: Cardiac Output; Dobutamine; Dopamine; Humans; Infant, Newborn; Myocardial Contraction; Shock, Cardiogenic | 1989 |
[Combination of dopamine and dobutamine in the differential therapy of acute and chronic myocardial failure].
Topics: Catecholamines; Clinical Trials as Topic; Dobutamine; Dopamine; Dose-Response Relationship, Drug; Drug Therapy, Combination; Heart; Heart Failure; Hemodynamics; Humans; Myocardial Contraction; Receptors, Adrenergic, beta; Renal Circulation; Shock, Cardiogenic; Vascular Resistance; Vasodilation | 1985 |
[Cardiogenic shock. Therapy].
Topics: Arrhythmias, Cardiac; Cardiac Tamponade; Dobutamine; Dopamine; Electric Countershock; Heart Rupture; Humans; Myocardial Infarction; Nitroglycerin; Nitroprusside; Pulmonary Embolism; Shock, Cardiogenic | 1986 |
Inotropic agents in the treatment of cardiogenic shock.
Topics: Blood Pressure; Cardiotonic Agents; Coronary Circulation; Dobutamine; Dopamine; Humans; Isoproterenol; Myocardium; Oxygen Consumption; Shock, Cardiogenic | 1985 |
20 trial(s) available for dobutamine and Shock, Cardiogenic
| Article | Year |
|---|---|
Implications of Myocardial Infarction on Management and Outcome in Cardiogenic Shock.
Topics: Dobutamine; Heart Arrest; Humans; Milrinone; Myocardial Infarction; Percutaneous Coronary Intervention; Shock, Cardiogenic; Stroke; Treatment Outcome | 2021 |
Lactate Clearance as a Surrogate for Mortality in Cardiogenic Shock: Insights From the DOREMI Trial.
Topics: Dobutamine; Hospital Mortality; Humans; Lactic Acid; Milrinone; Shock, Cardiogenic | 2022 |
No sex-based difference in cardiogenic shock: A post-hoc analysis of the DOREMI trial.
Topics: Dobutamine; Female; Heart Arrest; Humans; Male; Milrinone; Myocardial Infarction; Shock, Cardiogenic; Treatment Outcome | 2022 |
Arrhythmic Events and Mortality in Patients With Cardiogenic Shock on Inotropic Support: Results of the DOREMI Randomized Trial.
Topics: Arrhythmias, Cardiac; Dobutamine; Humans; Milrinone; Shock, Cardiogenic; Stroke Volume; Ventricular Function, Left | 2023 |
Milrinone as Compared with Dobutamine in the Treatment of Cardiogenic Shock.
Topics: Adrenergic beta-Agonists; Aged; Cardiotonic Agents; Comorbidity; Dobutamine; Double-Blind Method; Female; Hospital Mortality; Humans; Male; Middle Aged; Milrinone; Phosphodiesterase 3 Inhibitors; Shock, Cardiogenic | 2021 |
Impact of baseline beta-blocker use on inotrope response and clinical outcomes in cardiogenic shock: a subgroup analysis of the DOREMI trial.
Topics: Adrenergic beta-Antagonists; Aged; Aged, 80 and over; Cardiotonic Agents; Dobutamine; Dose-Response Relationship, Drug; Double-Blind Method; Female; Humans; Male; Middle Aged; Milrinone; Mortality; Outcome Assessment, Health Care; Shock, Cardiogenic | 2021 |
The association between mean arterial pressure and outcomes in patients with cardiogenic shock: insights from the DOREMI trial.
Topics: Arterial Pressure; Cardiotonic Agents; Dobutamine; Humans; Milrinone; Shock, Cardiogenic | 2021 |
Comparison of norepinephrine-dobutamine to epinephrine for hemodynamics, lactate metabolism, and organ function variables in cardiogenic shock. A prospective, randomized pilot study.
Topics: Acidosis, Lactic; Aged; Blood Gas Analysis; Blood Pressure; Cardiac Output; Dobutamine; Epinephrine; Female; Hemodynamics; Humans; Kidney; Lactates; Male; Middle Aged; Norepinephrine; Pyruvic Acid; Shock, Cardiogenic; Vasoconstrictor Agents | 2011 |
Levosimendan in patients with low-output heart failure: lessons from the LIDO trial.
Topics: Adrenergic beta-Agonists; Calcium Channels, L-Type; Cardiac Output, Low; Cardiotonic Agents; Death, Sudden, Cardiac; Dobutamine; Dose-Response Relationship, Drug; Double-Blind Method; Europe; Heart Failure; Heart Rate; Humans; Hydrazones; Infusions, Intravenous; Morbidity; Myocardial Contraction; Pulmonary Wedge Pressure; Pyridazines; Risk Factors; Severity of Illness Index; Shock, Cardiogenic; Simendan; Stroke Volume; Survival Analysis; Time; Treatment Outcome; Vasodilator Agents; Ventricular Dysfunction, Left | 2003 |
Cardiogenic shock after primary percutaneous coronary intervention: Effects of levosimendan compared with dobutamine on haemodynamics.
Topics: Aged; Angioplasty, Balloon, Coronary; Cardiac Output; Cardiotonic Agents; Dobutamine; Female; Humans; Hydrazones; Infusions, Intravenous; Middle Aged; Myocardial Infarction; Pyridazines; Shock, Cardiogenic; Simendan; Treatment Outcome | 2006 |
Effects of levosimendan versus dobutamine on long-term survival of patients with cardiogenic shock after primary coronary angioplasty.
Topics: Aged; Angioplasty, Balloon, Coronary; Cardiotonic Agents; Dobutamine; Female; Humans; Hydrazones; Male; Middle Aged; Myocardial Infarction; Proportional Hazards Models; Pyridazines; Shock, Cardiogenic; Simendan; Survival Rate; Treatment Outcome; Ventricular Dysfunction, Left | 2008 |
Effects of levosimendan versus dobutamine on left ventricular diastolic function in patients with cardiogenic shock after primary angioplasty.
Topics: Angioplasty, Balloon, Coronary; Cardiotonic Agents; Diastole; Dobutamine; Echocardiography, Doppler; Female; Humans; Hydrazones; Infusions, Intravenous; Male; Middle Aged; Pyridazines; Shock, Cardiogenic; Simendan; Ventricular Function, Left | 2008 |
Hemodynamic improvement following levosimendan treatment in patients with acute myocardial infarction and cardiogenic shock.
Topics: Angioplasty, Balloon, Coronary; Cardiotonic Agents; Catecholamines; Dobutamine; Female; Hemodynamics; Humans; Hydrazones; Infusions, Intravenous; Male; Middle Aged; Pyridazines; Shock, Cardiogenic; Simendan | 2007 |
[Use of dobutamine in the treatment of post-infarction shock].
Topics: Aged; Catecholamines; Clinical Trials as Topic; Dobutamine; Female; Humans; Male; Middle Aged; Myocardial Infarction; Shock, Cardiogenic | 1983 |
[Therapy of cardiogenic shock with dobutamine and nitroglycerin].
Topics: Adult; Aged; Cardiomyopathies; Catecholamines; Dobutamine; Drug Evaluation; Drug Therapy, Combination; Female; Heart Defects, Congenital; Hemodynamics; Humans; Male; Middle Aged; Nitroglycerin; Shock, Cardiogenic; Time Factors | 1983 |
Comparison of haemodynamic responses to dobutamine and salbutamol in cardiogenic shock after acute myocardial infarction.
Topics: Aged; Albuterol; Cardiac Output; Catecholamines; Clinical Trials as Topic; Dobutamine; Female; Hemodynamics; Humans; Male; Middle Aged; Myocardial Infarction; Random Allocation; Shock, Cardiogenic | 1982 |
Combined hemodynamic effects of dopamine and dobutamine in cardiogenic shock.
Topics: Aged; Blood Pressure; Catecholamines; Dobutamine; Dopamine; Drug Combinations; Female; Hemodynamics; Humans; Male; Middle Aged; Shock, Cardiogenic; Vascular Resistance | 1983 |
Comparative hemodynamic effects of dopamine and dobutamine in patients with acute cardiogenic circulatory collapse.
Topics: Acute Disease; Aged; Blood Pressure; Cardiac Output; Catecholamines; Dobutamine; Dopamine; Female; Heart Rate; Hemodynamics; Humans; Hypotension; Male; Middle Aged; Myocardial Infarction; Shock, Cardiogenic | 1982 |
[Differential therapy of cardiogenic shock with dopamine/milrinone in comparison with dopamine/dobutamine].
Topics: Aged; Blood Pressure; Cardiotonic Agents; Dobutamine; Dopamine; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Therapy, Combination; Female; Heart Rate; Hemodynamics; Humans; Male; Middle Aged; Milrinone; Nitroglycerin; Pyridones; Shock, Cardiogenic; Stroke Volume | 1996 |
[Combination of dopamine and dobutamine in the differential therapy of acute and chronic myocardial failure].
Topics: Catecholamines; Clinical Trials as Topic; Dobutamine; Dopamine; Dose-Response Relationship, Drug; Drug Therapy, Combination; Heart; Heart Failure; Hemodynamics; Humans; Myocardial Contraction; Receptors, Adrenergic, beta; Renal Circulation; Shock, Cardiogenic; Vascular Resistance; Vasodilation | 1985 |
71 other study(ies) available for dobutamine and Shock, Cardiogenic
| Article | Year |
|---|---|
Milrinone as Compared with Dobutamine in the Treatment of Cardiogenic Shock.
Topics: Cardiotonic Agents; Dobutamine; Epinephrine; Humans; Milrinone; Shock, Cardiogenic | 2021 |
Milrinone as Compared with Dobutamine in the Treatment of Cardiogenic Shock.
Topics: Cardiotonic Agents; Dobutamine; Epinephrine; Humans; Milrinone; Shock, Cardiogenic | 2021 |
Milrinone as Compared with Dobutamine in the Treatment of Cardiogenic Shock. Reply.
Topics: Cardiotonic Agents; Dobutamine; Epinephrine; Humans; Milrinone; Shock, Cardiogenic | 2021 |
Venoarterial extracorporeal membrane oxygenation flow or dobutamine to improve microcirculation during ECMO for refractory cardiogenic shock.
Topics: Dobutamine; Extracorporeal Membrane Oxygenation; Humans; Microcirculation; Prospective Studies; Retrospective Studies; Shock, Cardiogenic | 2022 |
Epidemiology, monitoring, and treatment strategy in cardiogenic shock. A multinational cross-sectional survey of ESC-acute cardiovascular care association research section.
Topics: Cross-Sectional Studies; Dobutamine; Dopamine; Humans; Lactates; Norepinephrine; Percutaneous Coronary Intervention; Shock, Cardiogenic; Treatment Outcome | 2022 |
[Chemical Stability after Mixing Continuous Infusion Drugs Used to Treat Cardiogenic Shock].
Topics: Dobutamine; Humans; Milrinone; Norepinephrine; Pharmaceutical Preparations; Shock, Cardiogenic | 2022 |
Management and clinical outcomes of cardiogenic shock in King Abdulaziz University Hospital: A retrospective study.
Topics: Digoxin; Dobutamine; Dopamine; Epinephrine; Hospital Mortality; Hospitals; Humans; Intra-Aortic Balloon Pumping; Percutaneous Coronary Intervention; Retrospective Studies; Shock, Cardiogenic; Treatment Outcome | 2023 |
Improved mortality and haemodynamics with milrinone in cardiogenic shock due to acute decompensated heart failure.
Topics: Dobutamine; Heart Failure; Hemodynamics; Humans; Milrinone; Retrospective Studies; Shock, Cardiogenic | 2023 |
Characteristics, management, and outcomes of active cancer patients with cardiogenic shock.
Topics: Aged; Aged, 80 and over; Dobutamine; Female; Humans; Male; Middle Aged; Neoplasms; Norepinephrine; Prospective Studies; Shock, Cardiogenic | 2023 |
Extracorporeal membrane oxygenation support in a patient with pheochromocytoma stress myocardyopathy.
Topics: Adrenal Gland Neoplasms; Adrenalectomy; Adult; Combined Modality Therapy; Dobutamine; Emergencies; Extracorporeal Membrane Oxygenation; Female; Humans; Hypertension; Multiple Organ Failure; Norepinephrine; Pheochromocytoma; Respiration, Artificial; Shock, Cardiogenic; Takotsubo Cardiomyopathy; Tomography, X-Ray Computed | 2018 |
Comparative Effectiveness and Safety Between Milrinone or Dobutamine as Initial Inotrope Therapy in Cardiogenic Shock.
Topics: Aged; Aged, 80 and over; Cardiotonic Agents; Dobutamine; Female; Hemodynamics; Humans; Male; Middle Aged; Milrinone; Retrospective Studies; Shock, Cardiogenic | 2019 |
Treatments targeting inotropy.
Topics: Acute Disease; Animals; Antioxidants; Calcium; Cardiotonic Agents; Case-Control Studies; Catecholamines; Clinical Trials as Topic; Diastole; Dobutamine; Dogs; Energy Metabolism; Excitation Contraction Coupling; Heart Failure; Humans; Mitochondria; Models, Animal; Myocardial Contraction; Nitrogen Oxides; Oxidation-Reduction; Phosphodiesterase Inhibitors; Placebos; Receptors, Adrenergic; Sarcomeres; Shock, Cardiogenic; Simendan; Swine; Systole; Urea | 2019 |
Dobutamine induced cardiogenic shock due to systolic anterior motion after mitral valve repair.
Topics: Adult; Cardiotonic Agents; Dobutamine; Echocardiography, Transesophageal; Humans; Male; Mitral Valve; Mitral Valve Insufficiency; Shock, Cardiogenic | 2013 |
Low-dose vasopressin improves cardiac function in newborn piglets with acute hypoxia-reoxygenation.
Topics: Animals; Animals, Newborn; Asphyxia Neonatorum; Cardiac Output; Dobutamine; Glutathione; Heart Ventricles; Hypoxia; Lactic Acid; Lipid Peroxides; Mesenteric Artery, Superior; Oxygen; Reperfusion Injury; Shock, Cardiogenic; Swine; Troponin I; Vasopressins | 2013 |
Beta-blocker therapy in cardiogenic shock: a therapeutical dilemma.
Topics: Cardiotonic Agents; Dobutamine; Humans; Male; Mitral Valve; Shock, Cardiogenic | 2013 |
Conventional hemodynamic resuscitation may fail to optimize tissue perfusion: an observational study on the effects of dobutamine, enoximone, and norepinephrine in patients with acute myocardial infarction complicated by cardiogenic shock.
Topics: Aged; Aged, 80 and over; Capillaries; Dobutamine; Enoximone; Female; Hemodynamics; Humans; Male; Microcirculation; Middle Aged; Myocardial Infarction; Norepinephrine; Perfusion; Pulmonary Circulation; Resuscitation; Shock, Cardiogenic; Treatment Outcome | 2014 |
Back from the brink: catastrophic antiphospholipid syndrome.
Topics: Adult; Anticoagulants; Antiphospholipid Syndrome; Cardiotonic Agents; Cyclophosphamide; Dobutamine; Extracorporeal Membrane Oxygenation; Female; Heparin; Humans; Immunoglobulins, Intravenous; Immunosuppressive Agents; Methylprednisolone; Mitral Valve Insufficiency; Plasmapheresis; Shock, Cardiogenic; Warfarin | 2015 |
Extensive variability in vasoactive agent therapy: a nationwide survey in Chinese intensive care units.
Topics: Data Collection; Dobutamine; Dopamine; Humans; Intensive Care Units; Norepinephrine; Shock; Shock, Cardiogenic; Shock, Septic; Surveys and Questionnaires; Vasoconstrictor Agents; Vasodilator Agents | 2015 |
Intra-aortic balloon pump (IABP) rescue therapy for refractory cardiogenic shock due to scorpion sting envenomation.
Topics: Activities of Daily Living; Adult; Animals; Antihypertensive Agents; Blood Pressure; Cardiotonic Agents; Dobutamine; Dose-Response Relationship, Drug; Female; Humans; Intra-Aortic Balloon Pumping; Myocardial Contraction; Prazosin; Scorpion Stings; Scorpions; Shock, Cardiogenic | 2016 |
Does ivabradine balance dobutamine effects in cardiogenic shock? A promising new strategy.
Topics: Benzazepines; Dobutamine; Humans; Ivabradine; Shock, Cardiogenic | 2016 |
Percutaneous management of massive pulmonary thromboembolism.
Topics: Adult; Aged, 80 and over; Combined Modality Therapy; Contraindications, Drug; Dobutamine; Endovascular Procedures; Extracorporeal Membrane Oxygenation; Female; Humans; Middle Aged; Norepinephrine; Out-of-Hospital Cardiac Arrest; Pulmonary Embolism; Shock, Cardiogenic; Thrombolytic Therapy | 2017 |
A comparison of central and mixed venous oxygen saturation in circulatory failure.
Topics: Aged; Cardiac Output; Cardiotonic Agents; Catheterization, Swan-Ganz; Dobutamine; Female; Heart Failure; Heart Function Tests; Humans; Intra-Aortic Balloon Pumping; Male; Middle Aged; Norepinephrine; Oxygen; Respiration, Artificial; ROC Curve; Sample Size; Shock, Cardiogenic; Shock, Septic; Vasoconstrictor Agents | 2010 |
Inotropic therapy for cardiac low output syndrome: comparison of hemodynamic effects of dopamine/dobutamine versus dopamine/dopexamine.
Topics: Aged; Blood Pressure; Cardiac Output, Low; Cardiotonic Agents; Dobutamine; Dopamine; Female; Hemodynamics; Humans; Male; Middle Aged; Myocardium; Oxygen Consumption; Respiration, Artificial; Retrospective Studies; Shock, Cardiogenic | 2008 |
Echocardiographic guidance in treatment of cardiogenic shock complicating transient left ventricular apical ballooning syndrome.
Topics: Adrenergic beta-Agonists; Adrenergic beta-Antagonists; Aged; Cineangiography; Combined Modality Therapy; Coronary Angiography; Dobutamine; Echocardiography, Doppler; Electrocardiography; Female; Hemodynamics; Humans; Intra-Aortic Balloon Pumping; Metoprolol; Shock, Cardiogenic; Takotsubo Cardiomyopathy; Treatment Outcome | 2009 |
Intra-aortic balloon pump in toxic myocarditis due to aluminum phosphide poisoning.
Topics: Aluminum Compounds; Cardiotonic Agents; Dobutamine; Drug Therapy, Combination; Female; Gastric Lavage; Humans; Intra-Aortic Balloon Pumping; Myocarditis; Norepinephrine; Pesticides; Phosphines; Shock, Cardiogenic; Suicide, Attempted; Treatment Outcome; Young Adult | 2009 |
Superiority of levosimendan over dobutamine in right ventricle failure.
Topics: Cardiotonic Agents; Critical Care; Critical Illness; Dobutamine; Female; Heart Function Tests; Humans; Hydrazones; Hypertension, Pulmonary; Intensive Care Units; Male; Myocardial Infarction; Prognosis; Pyridazines; Shock, Cardiogenic; Simendan; Survival Rate; Treatment Outcome; Vascular Resistance; Ventricular Dysfunction, Right | 2010 |
Dobutamine-norepinephrine, but not vasopressin, restores the ventriculoarterial matching in experimental cardiogenic shock.
Topics: Animals; Cardiotonic Agents; Disease Models, Animal; Dobutamine; Drug Therapy, Combination; Heart Failure; Hemodynamics; Male; Norepinephrine; Orchiectomy; Shock, Cardiogenic; Swine; Vasodilator Agents; Vasopressins; Ventricular Function, Left | 2010 |
Defining refractory myocardial infarction-associated cardiogenic shock: an ongoing elusive challenge.
Topics: Cardiopulmonary Resuscitation; Combined Modality Therapy; Dobutamine; Extracorporeal Membrane Oxygenation; Female; Humans; Male; Myocardial Infarction; Prognosis; Risk Assessment; Shock, Cardiogenic; Survival Analysis | 2011 |
Essential lessons in cardiogenic shock: epinephrine versus norepinephrine/dobutamine.
Topics: Dobutamine; Epinephrine; Humans; Norepinephrine; Shock, Cardiogenic; Vasoconstrictor Agents | 2011 |
Resolution of shock-induced aortic regurgitation with an intraaortic balloon pump.
Topics: Aged, 80 and over; Aortic Valve Insufficiency; Bradycardia; Cardiotonic Agents; Coronary Angiography; Coronary Stenosis; Dobutamine; Echocardiography, Transesophageal; Humans; Intra-Aortic Balloon Pumping; Male; Norepinephrine; Shock, Cardiogenic | 2011 |
Churg-Strauss syndrome presenting with acute myocarditis and cardiogenic shock.
Topics: Bronchodilator Agents; Churg-Strauss Syndrome; Diagnosis, Differential; Dobutamine; Eosinophils; Granuloma; Humans; Magnetic Resonance Imaging, Cine; Male; Myocarditis; Norepinephrine; Shock, Cardiogenic; Young Adult | 2012 |
[Cardiogenic shock after venlafaxine poisoning].
Topics: Adult; Anticonvulsants; Cardiotonic Agents; Cyclohexanols; Diuretics; Dobutamine; Electrocardiography; Female; Furosemide; Humans; Hypotension; Isosorbide Dinitrate; Respiration, Artificial; Seizures; Selective Serotonin Reuptake Inhibitors; Shock, Cardiogenic; Suicide, Attempted; Vasodilator Agents; Venlafaxine Hydrochloride | 2011 |
[Occurrence of severe cardiac alterations in Amanita proxima poisoning: two original observations].
Topics: Adrenergic beta-Agonists; Adult; Amanita; Diuretics; Dobutamine; Electrocardiography; Female; Furosemide; Heart Failure; Hemodiafiltration; Hemodynamics; Humans; Long QT Syndrome; Male; Middle Aged; Mushroom Poisoning; Nausea; Resuscitation; Shock, Cardiogenic; Ultrasonography; Ventricular Dysfunction, Left | 2012 |
Predictors of survival in unselected patients with acute myocardial infarction requiring continuous catecholamine support.
Topics: Aged; Blood Pressure; Cardiopulmonary Resuscitation; Cardiotonic Agents; Catecholamines; Clinical Trials as Topic; Dobutamine; Dopamine; Electrocardiography; Epinephrine; Female; Humans; Male; Middle Aged; Multivariate Analysis; Myocardial Infarction; Norepinephrine; Retrospective Studies; Risk Factors; Shock, Cardiogenic; Survival Rate | 2002 |
[Non cardiac surgery in patient with coronary stenting: think sirolimus now!].
Topics: Aged; Angioplasty, Balloon, Coronary; Breast; Breast Neoplasms; Cardiotonic Agents; Dobutamine; Female; Humans; Immunosuppressive Agents; Shock, Cardiogenic; Sirolimus; Stents; Thrombosis | 2003 |
Natriuretic peptides and E-selectin as predictors of acute deterioration in patients with inotrope-dependent heart failure.
Topics: Adolescent; Adult; Aged; Biomarkers; C-Reactive Protein; Dobutamine; Dopamine; Drug Administration Schedule; Drug Therapy, Combination; E-Selectin; Enoximone; Epidemiologic Methods; Epinephrine; Female; Heart Failure; Humans; Male; Middle Aged; Natriuretic Peptide, Brain; Natriuretic Peptides; Nerve Tissue Proteins; Norepinephrine; Peptide Fragments; Prognosis; Shock, Cardiogenic | 2005 |
[Reversible cardiogenic shock under 5-fluorouracil treatment].
Topics: Adenocarcinoma; Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Cardiotonic Agents; Colorectal Neoplasms; Dobutamine; Dopamine; Fluorouracil; Humans; Male; Middle Aged; Shock, Cardiogenic | 2005 |
[Therapy of acute decompensated heart failure with levosimendan].
Topics: Adult; Aged; Calcium Channel Agonists; Cardiotonic Agents; Conscious Sedation; Critical Care; Dobutamine; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Therapy, Combination; Electrocardiography; Female; Heart Failure; Hemodynamics; Humans; Hydrazones; Male; Middle Aged; Norepinephrine; Pyridazines; Shock, Cardiogenic; Simendan | 2006 |
Nonketotic hyperglycemic coma in toddlers after unintentional methadone ingestion.
Topics: Accidents, Home; Animals; Brain Damage, Chronic; Child, Preschool; Diabetes Mellitus, Type 1; Diagnostic Errors; Dobutamine; Drug Packaging; Epinephrine; Female; France; Humans; Hyperglycemic Hyperosmolar Nonketotic Coma; Infant; Insulin; Islets of Langerhans; Male; Methadone; Mice; Multiple Organ Failure; Myocardial Infarction; Naloxone; Receptor, Insulin; Receptors, Opioid, mu; Shock, Cardiogenic; Sweetening Agents; Time Factors | 2006 |
[Tako-tsubo syndrome: a case report].
Topics: Acute Disease; Aged; Combined Modality Therapy; Diagnosis, Differential; Dobutamine; Epinephrine; Female; Heart Arrest; Heart Block; Heparin; Humans; Liver Failure; Myocardial Infarction; Oxygen Inhalation Therapy; Radiography; Shock, Cardiogenic; Syndrome; Vasoconstrictor Agents; Ventricular Dysfunction, Left | 2007 |
[Severe bencyctane intoxication--a case report].
Topics: Adult; Bencyclane; Calcium Channel Blockers; Dobutamine; Dopamine; Drug Overdose; Fluid Therapy; Humans; Male; Poisoning; Pulmonary Edema; Respiration, Artificial; Shock, Cardiogenic; Suicide, Attempted; Treatment Outcome; Vasoconstrictor Agents; Vasodilator Agents | 2007 |
Inotropic therapy for cardiac low output syndrome: comparison of hemodynamic effects of dopamine/dobutamine versus dopamine/dopexamine.
Topics: Aged; Cardiac Output, Low; Cardiotonic Agents; Dobutamine; Dopamine; Drug Therapy, Combination; Female; Heart; Hemodynamics; Humans; Male; Middle Aged; Myocardium; Oxygen Consumption; Retrospective Studies; Shock, Cardiogenic; Treatment Outcome; Vasodilator Agents | 2007 |
[Cardiogenic shock in neuroleptic poisoning. Reversibility by a bolus of dobutamine].
Topics: Adult; Antipsychotic Agents; Catecholamines; Dobutamine; Humans; Male; Shock, Cardiogenic | 1982 |
Effects of 2-[(5-chloro-2-methoxyphenyl)azo]-1H-imidazole (M6434) on hemorrhagic, cardiogenic, and endotoxin shock in rats and rabbits.
Topics: Adenosine Triphosphate; Animals; Blood Pressure; Diuresis; Dobutamine; Dopamine; Heart Rate; Imidazoles; Male; Myocardium; Phosphocreatine; Rabbits; Rats; Rats, Inbred Strains; Renal Circulation; Shock, Cardiogenic; Shock, Hemorrhagic; Shock, Septic; Sympathomimetics | 1984 |
[Catecholamines in internal medicine emergencies].
Topics: Acute Disease; Catecholamines; Coronary Disease; Dobutamine; Dopamine; Heart Failure; Hemodynamics; Humans; Myocardial Infarction; Oxygen Consumption; Shock, Cardiogenic; Shock, Septic | 1984 |
[Dobutamine, dopamine, and other catecholamine-like substances for myocardial infarct].
Topics: Catecholamines; Dobutamine; Dopamine; Humans; Myocardial Infarction; Norepinephrine; Shock, Cardiogenic | 1983 |
[Therapy of acute myocardial infarct].
Topics: Acute Disease; Dobutamine; Dopamine; Drug Therapy, Combination; Hemodynamics; Heparin; Humans; Myocardial Infarction; Nitroglycerin; Nitroprusside; Shock, Cardiogenic | 1980 |
Shock in acute myocardial infarction: evolution of physiologic therapy.
Topics: Dobutamine; Humans; Intra-Aortic Balloon Pumping; Myocardial Infarction; Nitroprusside; Shock, Cardiogenic; Vasoconstrictor Agents; Vasodilator Agents | 1983 |
Hemodynamic effects of sulmazol (ARL-115 BS), a new vasodilator and positive inotropic agent, in patients with cardiogenic shock.
Topics: Adult; Cardiac Output; Cardiotonic Agents; Dobutamine; Dopamine; Drug Therapy, Combination; Female; Hemodynamics; Humans; Imidazoles; Intra-Aortic Balloon Pumping; Male; Middle Aged; Shock, Cardiogenic; Vasodilator Agents | 1983 |
Treatment of acute left heart failure using dobutamine and intraaortic counterpulsation. Animal experiments and first clinical experiences.
Topics: Adult; Animals; Assisted Circulation; Catecholamines; Coronary Artery Bypass; Coronary Circulation; Coronary Vessels; Dobutamine; Dogs; Hemodynamics; Humans; Intra-Aortic Balloon Pumping; Middle Aged; Shock, Cardiogenic | 1981 |
[Standard therapy of acute myocardial infarction.--II. Management of hemodynamic complications. (author's transl)].
Topics: Analgesics; Atropine; Digoxin; Dobutamine; Dopamine; Drug Therapy, Combination; Heart Failure; Heart Rupture; Hemodynamics; Humans; Hypertension; Hypotension; Myocardial Infarction; Propranolol; Shock, Cardiogenic; Vasodilator Agents | 1981 |
[Hemodynamic effect of dobutamine in cardiogenic shock].
Topics: Aged; Catecholamines; Dobutamine; Female; Hemodynamics; Humans; Male; Middle Aged; Myocardial Infarction; Shock, Cardiogenic | 1981 |
[Comparative studies on the hemodynamic effects of dobutamine, dopamine, and isoproterenol in dogs in experimental shock (author's transl)].
Topics: Animals; Blood Pressure; Catecholamines; Coronary Circulation; Dobutamine; Dogs; Dopamine; Female; Heart Rate; Hemodynamics; Isoproterenol; Male; Myocardium; Oxygen Consumption; Shock, Cardiogenic | 1980 |
Counterpulsation and dobutamine. Their use in treatment of cardiogenic shock due to right ventricular infarct.
Topics: Assisted Circulation; Blood Pressure; Cardiac Output, Low; Catecholamines; Dobutamine; Echocardiography; Heart; Humans; Intra-Aortic Balloon Pumping; Male; Middle Aged; Myocardial Infarction; Radionuclide Imaging; Shock, Cardiogenic | 1981 |
Left ventricular failure complicating severe pediatric burn injuries.
Topics: Adolescent; Analysis of Variance; Burns; Catheterization, Swan-Ganz; Child; Child, Preschool; Dobutamine; Fluid Therapy; Heart Arrest; Humans; Infant; Respiratory Insufficiency; Resuscitation; Retrospective Studies; Shock, Cardiogenic; Shock, Traumatic; Ventricular Dysfunction, Left | 1995 |
Prognostic significance of early cardiac index measurements in severely burned patients.
Topics: Adult; Analysis of Variance; Burns; Dobutamine; Heart Function Tests; Hemodynamics; Humans; Injury Severity Score; Middle Aged; Prognosis; Retrospective Studies; Shock, Cardiogenic; Survivors | 1994 |
Efficacy of epinephrine therapy in shock complicating pulmonary embolism.
Topics: Cardiac Output, Low; Dilatation, Pathologic; Dobutamine; Epinephrine; Female; Humans; Hypotension; Middle Aged; Norepinephrine; Pulmonary Embolism; Recombinant Proteins; Shock, Cardiogenic; Urokinase-Type Plasminogen Activator; Ventricular Function, Right | 1993 |
Effect of protracted dobutamine infusion on survival of patients in cardiogenic shock treated with intraaortic balloon pumping.
Topics: Blood Pressure; Central Venous Pressure; Dobutamine; Female; Fluid Therapy; Heart Rate; Humans; Infusion Pumps; Infusions, Intravenous; Intra-Aortic Balloon Pumping; Male; Middle Aged; Myocardial Infarction; Norepinephrine; Pulmonary Wedge Pressure; Shock, Cardiogenic; Survival Rate; Time Factors; Urine | 1993 |
The use of glucagon in a case of calcium channel blocker overdose.
Topics: Acute Disease; Aged; Bradycardia; Dobutamine; Dopamine; Drug Overdose; Drug Therapy, Combination; Female; Glucagon; Humans; Hypotension; Shock, Cardiogenic; Verapamil | 1993 |
No interaction between dopamine and phenytoin.
Topics: Anti-Arrhythmia Agents; Cardiotonic Agents; Dobutamine; Dopamine; Drug Interactions; Drug Therapy, Combination; Humans; Male; Middle Aged; Phenytoin; Shock, Cardiogenic | 1995 |
The effects of dopamine, dobutamine and amrinone on mitochondrial function in cardiogenic shock.
Topics: Adenosine Triphosphatases; Amrinone; Animals; Cardiotonic Agents; Carrier Proteins; Dobutamine; Dogs; Dopamine; Electron Transport Complex I; Electron Transport Complex IV; Energy Metabolism; Membrane Proteins; Mitochondria, Heart; Mitochondrial Proton-Translocating ATPases; Myocardial Infarction; NADH, NADPH Oxidoreductases; Shock, Cardiogenic; Ventricular Function, Left | 1997 |
Conversion of extracorporeal membrane oxygenation to non-pulsatile left ventricular assist device. Is it out-of-date for non-pulsatile LVAD?
Topics: Cardiotonic Agents; Clinical Protocols; Coronary Artery Bypass; Dobutamine; Dopamine; Dopamine Agents; Extracorporeal Membrane Oxygenation; Heart Transplantation; Heart-Assist Devices; Humans; Male; Middle Aged; Myocardial Infarction; Respiratory Insufficiency; Shock, Cardiogenic; Time Factors; Ventilator Weaning | 2001 |
[Sympathomimetic amines].
Topics: Dobutamine; Dopamine; Dose-Response Relationship, Drug; Drug Therapy, Combination; Epinephrine; Kidney; Shock, Cardiogenic; Shock, Septic; Sympathomimetics; Vasoconstrictor Agents | 1979 |
Full recovery after a chloroquine suicide attempt.
Topics: Adult; Chloroquine; Combined Modality Therapy; Diazepam; Dobutamine; Epinephrine; Female; Humans; Poisoning; Pulmonary Edema; Respiration, Artificial; Shock, Cardiogenic; Suicide, Attempted; Ventricular Fibrillation | 1991 |
[Medical strategy in patients awaiting emergency heart transplantation].
Topics: Adult; Assisted Circulation; Cardiac Output, Low; Cardiotonic Agents; Contraindications; Critical Care; Diuretics; Dobutamine; Dopamine; Emergencies; Enoximone; Female; Heart Failure; Heart Transplantation; Hemodynamics; Humans; Imidazoles; Infusions, Intravenous; Injections, Intravenous; Male; Middle Aged; Shock, Cardiogenic | 1990 |
[A case report of right ventricular infarction clearly detected by transesophageal echocardiography].
Topics: Aged; Dobutamine; Echocardiography; Female; Heart Ventricles; Humans; Myocardial Infarction; Nitroprusside; Shock, Cardiogenic | 1990 |
Hemodynamic and oxygen transport variables in cardiogenic shock secondary to acute myocardial infarction, and response to treatment.
Topics: Aged; Dobutamine; Female; Fluid Therapy; Hemodynamics; Humans; Male; Middle Aged; Myocardial Infarction; Oxygen; Prospective Studies; Resuscitation; Shock, Cardiogenic | 1990 |
Measurement of cardiac reserve in cardiogenic shock: implications for prognosis and management.
Topics: Adult; Aged; Cardiac Output; Dobutamine; Female; Heart; Hemodynamics; Humans; Male; Middle Aged; Prognosis; Prospective Studies; Shock, Cardiogenic | 1990 |
[Pharmacotherapy of cardiogenic shock].
Topics: Adrenergic Agonists; Cardiac Surgical Procedures; Dobutamine; Dopamine; Drug Therapy, Combination; Humans; Myocardial Infarction; Postoperative Complications; Shock, Cardiogenic; Vasodilator Agents | 1988 |
Use of dobutamine for treatment of shock liver syndrome.
Topics: Adult; Dobutamine; Female; Heart Valve Prosthesis; Hemodynamics; Humans; Liver Diseases; Liver Function Tests; Mitral Valve; Postoperative Complications; Shock, Cardiogenic | 1988 |
[Significance of nitrates in acute therapy of heart failure with and without lung edema].
Topics: Cardiac Output, Low; Cardiomyopathy, Dilated; Dobutamine; Drug Therapy, Combination; Heart Failure; Hemodynamics; Humans; Isosorbide Dinitrate; Nitrates; Nitroglycerin; Pulmonary Edema; Regional Blood Flow; Shock, Cardiogenic | 1985 |